Literature DB >> 16109361

Neurological complications of HIV infection.

Justin C McArthur1, Bruce J Brew, Avi Nath.   

Abstract

Cognitive disorders, vacuolar myelopathy, and sensory neuropathies associated with HIV are the most common disorders in patients with HIV AIDS, and are the focus of this review. These disorders are treatable and of those associated with HIV AIDS the pathogenic mechanisms are the most understood. Although triggered by productive HIV macrophage infections, aberrant immune activation plays a major role in inducing the CNS disorders. Novel therapies aimed at these inflammatory mechanisms can be effective. The sensory neuropathies associated with HIV infection are a major cause of morbidity; incidence may be increased by the toxic effects of specific antiretroviral drugs within the peripheral nervous system.

Entities:  

Mesh:

Year:  2005        PMID: 16109361     DOI: 10.1016/S1474-4422(05)70165-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  217 in total

1.  Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection.

Authors:  A B Ragin; Y Wu; P Storey; B A Cohen; R R Edelman; L G Epstein
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

2.  ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling.

Authors:  Sheila M Adams; Marina V Aksenova; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  Synapse       Date:  2010-11       Impact factor: 2.562

3.  Persistent Peripheral Nervous System Damage in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy.

Authors:  Jamie L Dorsey; Lisa M Mangus; Peter Hauer; Gigi J Ebenezer; Suzanne E Queen; Victoria A Laast; Robert J Adams; Joseph L Mankowski
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

4.  The new epidemic of non-communicable disease in people living with the human immunodeficiency virus.

Authors:  R Dawson; W N Rom; K Dheda; E D Bateman
Journal:  Public Health Action       Date:  2013-03-21

5.  Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task.

Authors:  April D Thames; Philip Sayegh; Kevin Terashima; Jessica M Foley; Andrew Cho; Alyssa Arentoft; Charles H Hinkin; Susan Y Bookheimer
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

Review 6.  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.

Authors:  Arun K Ghosh; Heather L Osswald; Gary Prato
Journal:  J Med Chem       Date:  2016-01-22       Impact factor: 7.446

7.  Transcriptome analysis of HIV-infected peripheral blood monocytes: gene transcripts and networks associated with neurocognitive functioning.

Authors:  Andrew J Levine; Steve Horvath; Eric N Miller; Elyse J Singer; Paul Shapshak; Gayle C Baldwin; Otoniel Martínez-Maza; Mallory D Witt; Peter Langfelder
Journal:  J Neuroimmunol       Date:  2013-09-26       Impact factor: 3.478

8.  Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array.

Authors:  Thorsten Nolting; Antje Lindecke; Eleni Koutsilieri; Matthias Maschke; Ingo-W Husstedt; Sieghart Sopper; Olaf Stüve; Hans-Peter Hartung; Gabriele Arendt
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

9.  Atrophy and Death of Nonpeptidergic and Peptidergic Nociceptive Neurons in SIV Infection.

Authors:  Jake A Robinson; Guy Guenthner; Rebecca Warfield; Jessica R Kublin; Mandy D Smith; Masoud Shekarabi; Andrew D Miller; Tricia H Burdo
Journal:  Am J Pathol       Date:  2020-04-01       Impact factor: 4.307

10.  Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model.

Authors:  Gigi J Ebenezer; Victoria A Laast; Brandon Dearman; Peter Hauer; Patrick M Tarwater; Robert J Adams; M Christine Zink; Justin C McArthur; Joseph L Mankowski
Journal:  J Comp Neurol       Date:  2009-05-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.